This inventor holds 10 USPTO granted patents and 2 published patent applications. Top assignees: Astra Aktiebolag, Aktiebolaget Astra, Medivir Ab. Active years: 1996-2001.
Location History:
- S odert alje, SE (1996 - 1997)
- Södertälje, SE (2001)
Company Filing History:
8 out of 271 
1 out of 53 
1 out of 120 
Years Active: 1996-2001
Title: The Innovative Contributions of Daniel Dungan Sohn
Introduction
Daniel Dungan Sohn is a notable inventor based in Södertälje, Sweden. He has made significant contributions to the field of pharmaceuticals, holding a total of 10 patents. His work focuses on the development of compounds that are beneficial in treating various disorders of the central nervous system.
Latest Patents
Among his latest patents is a process for the manufacture of 3-N-N-dicyclobutylamino-8-fluoro-3, 4-dihydro-2H-1-benzopyran-5-carboxamide. This patent details a method for producing the racemic compound of the formula (I), along with its R-enantiomer (formula R-(I)) and its S-enantiomer (formula S-(I)). Additionally, he has developed chroman derivatives, specifically 3-amino-5-carbonylchromans, including their enantiomers and salts. These compounds are disclosed as active ingredients in pharmaceutical compositions aimed at treating 5-hydroxytryptamine-mediated disorders.
Career Highlights
Daniel has worked with prominent companies in the pharmaceutical industry, including Astra Aktiebolag and Medivir AB. His experience in these organizations has allowed him to refine his expertise in drug development and innovation.
Collaborations
Throughout his career, Daniel has collaborated with esteemed colleagues such as Lars George Johansson